Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Cases. May 6, 2022; 10(13): 4020-4032
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4020
Table 5 Comparison of multidetector computed tomography signs in death and survival groups

Survival group (n = 44)
Death group (n = 9)
P value
Embolus involvement length (%)0.311
≤ 20 mm12 (27.27)1 (11.11)
20-50 mm10 (22.73)1 (11.11)
≥ 50 mm22 (50.00)7 (77.78)
Embolus region (%)0.212
I4 (9.09)1 (11.11)
II1 (2.27)0 (0)
III2 (4.55)0 (0)
IV8 (18.18)0 (0)
I + II1 (2.27)1 (11.11)
III + IV17 (38.64)2 (22.22)
I + II + III1 (2.27)0 (0)
II + III + IV 6 (13.64)1 (11.11)
I + II + III + IV4 (9.09)4 (44.44)
Decreased intestinal wall enhancement (%)0.004
No23 (52.27)0 (0)
Yes21 (47.73)9 (100)
Intestinal wall thinning (%)0.002
No30 (68.18)1 (11.11)
Yes14 (31.82)8 (88.89)
Intestinal wall thickening (%)0.178
No34 (77.27)5 (55.56)
Yes10 (22.73)4 (44.44)
Pneumatosis intestinalis (%)0.007
No42 (95.45)6 (66.67)
Yes2 (4.55)3 (33.33)
Infarction of other organs (%)0.348
No27 (61.36)4 (44.44)
Yes17 (38.64)5 (55.56)
Mesenteric fat stranding (%)0.127
No22 (50)2 (22.22)
Yes22 (50)7 (77.78)